LATEST
Mon, Aug 31, 2026
Loading weather...
Business

AnaptysBio stock rating maintained at Outperform by Wolfe Research

AnaptysBio stock rating maintained at Outperform by Wolfe Research
Source: Investing.com - News

More details on this developing story will follow.

Original reporting: Investing.com - NewsRead original report →
Have feedback on this article?Report error or suggestion

Read More from Business

Science Applications Non-GAAP EPS of $3.01 beats by $0.70, revenue of $1.88B beats by $120M

Breaking News......

Read Article »

Cocoa prices are soaring again on weather-related supply concerns

Breaking News......

Read Article »

Arm CEO Rene Haas’ $800M compensation scheme faces investor backlash - report

Breaking News......

Read Article »
Return to Front Page

Subscribe to Our Newsletter

Get the latest breaking news and top stories delivered straight to your inbox.